Suitability of patient education materials on proton-pump inhibitors deprescribing: a focused review

  • Jérôme Nguyen-Soenen
  • Cédric Rat
  • Jean-Pascal FournierEmail author



Engaging patients in the process of deprescribing is a necessity. Several patient education materials have been developed for this purpose. The aim of this study was to assess the suitability of the existing patient education materials for proton-pump inhibitors deprescribing.


We conducted a targeted inventory of the available materials on scientific literature and known repositories. We evaluated their suitability with the Suitability Assessment of Materials (SAM) instrument. Materials were rated independently by two researchers and then discussed until consensus was reached.


Seven patient education materials were identified. Three materials (42.9%) were deemed “superior” and 4 (57.1%) were deemed “adequate”. Ratings were generally good in the categories of content, learning stimulation, motivation, typography and layout. The major weaknesses included the use of inappropriate graphics and the too demanding required reading grade level. These may decrease patient attention and comprehension and therefore the effectiveness of education materials.


Suitability of the patient education materials on proton-pump inhibitors deprescribing is overall satisfactory. Greater attention on readability, graphics and inclusion of summaries will be needed for development of future materials.


Deprescriptions Proton-pump inhibitors Patient education handout Primary care 



We would like to thank Sasha Mann for her help during the language editing of the manuscript.

Author contributions

JN, CR and JPF were involved in the conception of the study. JN was involved in the data collection. JN and JPF were involved in the data analysis. JN and JPF were involved in the data interpretation. JN drafted the first version of the manuscript. JN, CR and JPF read and approved the final manuscript. JN can be contacted for access to the dataset underlying the current analysis.

Compliance with ethical standards

Conflicts of interest

The authors declare that they have no conflict of interest.

Supplementary material

228_2019_2779_MOESM1_ESM.docx (70 kb)
ESM 1 (DOCX 70 kb)


  1. 1.
    Boghossian TA, Rashid FJ, Thompson W et al (2017) Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database Syst Rev.
  2. 2.
    Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, Grams ME (2016) Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 176:238–246. CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Furuya-Kanamori L, Stone JC, Clark J, McKenzie S, Yakob L, Paterson DL, Riley TV, Doi SA, Clements AC (2015) Comorbidities, exposure to medications, and the risk of community-acquired clostridium difficile infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 36:132–141. CrossRefPubMedGoogle Scholar
  4. 4.
    Filion KB, Chateau D, Targownik LE, Gershon A, Durand M, Tamim H, Teare GF, Ravani P, Ernst P, Dormuth CR, CNODES Investigators (2014) Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis. Gut 63:552–558. CrossRefPubMedGoogle Scholar
  5. 5.
    Eom C-S, Park SM, Myung S-K, Yun JM, Ahn JS (2011) Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies. Ann Fam Med 9:257–267. CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Gomm W, Fink A, Maier W et al (2016) Association of proton pump inhibitors with risk of dementia. JAMA Neurol 73:410–416. CrossRefPubMedGoogle Scholar
  7. 7.
    Shiraev TP, Bullen A (2018) Proton pump inhibitors and cardiovascular events: a systematic review. Heart Lung Circ 27:443–450. CrossRefPubMedGoogle Scholar
  8. 8.
    Prescribing & Medicines Team, NHS Digital (2019) Prescription cost analysis - England, 2018. Health and Social Care Information Centre. Accessed 26 Apr 2019
  9. 9.
    Othman F, Card TR, Crooks CJ (2016) Proton pump inhibitor prescribing patterns in the UK: a primary care database study. Pharmacoepidemiol Drug Saf 25:1079–1087. CrossRefPubMedGoogle Scholar
  10. 10.
    Reeve E, Gnjidic D, Long J, Hilmer S (2015) A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol 80:1254–1268. CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Wilsdon TD, Hendrix I, Thynne TRJ, Mangoni AA (2017) Effectiveness of interventions to deprescribe inappropriate proton pump inhibitors in older adults. Drugs Aging 34:265–287. CrossRefPubMedGoogle Scholar
  12. 12.
    Opondo D, Eslami S, Visscher S, de Rooij SE, Verheij R, Korevaar JC, Abu-Hanna A (2012) Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS One 7:e43617. CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Davidoff AJ, Miller GE, Sarpong EM, Yang E, Brandt N, Fick DM (2015) Prevalence of potentially inappropriate medication use in older adults using the 2012 Beers Criteria. J Am Geriatr Soc 63:486–500. CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Fajardo MA, Weir KR, Bonner C et al (2019) Availability and readability of patient education materials for deprescribing: an environmental scan. Br J Clin Pharmacol. CrossRefGoogle Scholar
  15. 15.
    Grey matters: a practical tool for searching health-related grey literature (2018). In: Ottawa: CADTH. Accessed 1 Nov 2018
  16. 16.
    Doak CC, Doak LG, Root JH (1996) Teaching patients with low literacy skills. Accessed 2 Apr 2019CrossRefGoogle Scholar
  17. 17.
    Williams AM, Muir KW, Rosdahl JA (2016) Readability of patient education materials in ophthalmology: a single-institution study and systematic review. BMC Ophthalmol:16.
  18. 18.
    Corcoran N, Ahmad F (2016) The readability and suitability of sexual health promotion leaflets. Patient Educ Couns 99:284–286. CrossRefPubMedGoogle Scholar
  19. 19.
    Farr JN, Jenkins JJ, Paterson DG (1951) Simplification of Flesch Reading Ease formula. J Appl Psychol 35:333–337. CrossRefGoogle Scholar
  20. 20.
    Clyne B, Smith SM, Hughes CM, Boland F, Bradley MC, Cooper JA, Fahey T, OPTI-SCRIPT study team (2015) Effectiveness of a multifaceted intervention for potentially inappropriate prescribing in older patients in primary care: a cluster-randomized controlled trial (OPTI-SCRIPT study). Ann Fam Med 13:545–553. CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Pratt NL, Kalisch Ellett LM, Sluggett JK, Gadzhanova SV, Ramsay EN, Kerr M, LeBlanc V, Barratt JD, Roughead EE (2017) Use of proton pump inhibitors among older Australians: national quality improvement programmes have led to sustained practice change. Int J Qual Health Care 29:75–82. CrossRefPubMedGoogle Scholar
  22. 22.
    Martin P, Tannenbaum C (2017) A realist evaluation of patients’ decisions to deprescribe in the EMPOWER trial. BMJ Open 7:e015959. CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Vermont Academic Detailing Program (2013) Stopping your proton pump inhibitor or “PPI.” Accessed 1 Apr 2019
  24. 24., Bruyere Research Institute (2018) Proton pump inhibitor deprescribing guideline information pamphlet. Accessed 1 Apr 2019
  25. 25.
    Thompson W, Farrell B, Welch V, Tugwell P, Way C, Richardson L, Bjerre LM (2019) Continuation or deprescribing of proton pump inhibitors: a consult patient decision aid. Can Pharm J 152:18–22. CrossRefGoogle Scholar
  26. 26., Bruyere Research Institute (2018) Proton pump inhibitor deprescribing infographic. Accessed 1 Apr 2019
  27. 27.
    Thompson W, Farrell B, Welch V, Tugwell P, Bjerre LM (2017) Should I continue taking my acid reflux medication? Design of a pilot before/after study evaluating a patient decision aid. Can Pharm J 150:19–23. CrossRefGoogle Scholar
  28. 28.
    Rhee RL, Feldt JMV, Schumacher HR, Merkel PA (2013) Readability and suitability assessment of patient education materials in rheumatic diseases. Arthritis Care Res 65:1702–1706. CrossRefGoogle Scholar
  29. 29.
    Parekh N, Ali K, Davies K, Rajkumar C (2018) Can supporting health literacy reduce medication-related harm in older adults? Ther Adv Drug Saf 9:167–170. CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Tuot DS, Davis E, Velasquez A, Banerjee T, Powe NR (2013) Assessment of printed patient-educational materials for chronic kidney disease. Am J Nephrol 38:184–194. CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Stacey D, Légaré F, Lewis K et al (2017) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev.

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of General Practice, Faculty of MedicineUniversity of NantesNantesFrance

Personalised recommendations